Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study

Figures & data

Table 1 Sociodemographic Characteristics of HIV-Infected Women Attending HIV Care and Treatment Clinics in Selected Hospitals of Southwest Ethiopia; 2018 (n=444)

Variables		Number	Percent
Age	20–29	111	25
	30–39	274	61.7
	>40	59	13.3
	Mean (±Std. Deviation)	34.43(±5.722)	-
Residence	Urban	325	73.2
	Rural	119	26.8
Educational status	No education	113	25.4
	Primary	189	42.6
	Secondary	82	18.5
	College/university	60	13.5
Marital status	Married	189	42.6
	Single	90	20.3
	Widowed	85	18.9
	Divorced	80	18.2
Occupation	Self-employee	152	34.2
	Unemployed	128	28.8
	Government employee	68	15
	Farmer	48	11
	Trader	48	11

Table 2 Reproductive Health Characteristics of HIV-Infected Women Attending Care and Treatment Clinics in Selected Hospitals of Southwest Ethiopia; 2018 (n=444)

Variables		Frequency	Percentage
Age at first sexual intercourse)	<15	234	52.7
	15–17	188	42.3
	>18	22	5
	Mean (±SD)	15.24 (±1.437)
Parity (n=351)	0	16	4.6
	1–4	250	71.2
	>5	85	24.2
Lifetime number of sexual partners	One	142	32
	Two or more	302	68
Ever history of STI	Yes	134	30.2
	No	310	69.8
Ever history of genital wart	Yes	90	20.3
	No	354	79.7
Ever use of oral contraceptive	Yes	323	72.7
	No	121	27.3
Time of last menstrual period	< 12 months ago	396	89.2
	≥ 12 months ago	48	10.8
History of abortion (N=351)	Yes	126	35.9
	No	225	64.1

Table 3 Immunological Characteristics of HIV-Infected Women in Three Screening Centers, Southwest Ethiopia, 2018 (N=444)

Variables		Frequency	Percentage
Current use of HAART	Yes	280	63
	No	164	37
Current HAART use duration (N=280)	< 12 months	58	20.7
	12–36 months	99	35.3
	>36 months	123	44
Base line CD4 count before HAART (N=280)	<200	245	87.5
	>200	35	12.5
	Mean (±Std. Deviation)	130.9(SD±52.4)
Recent CD4 count after HAART (N=280)	<200	72	25.7
	>200	208	74.3
	Mean (±Std. Deviation)	312.93(SD±219.38)
Ever history of smoking	Yes	32	7.2
	No	412	92.8
Who clinical stage	Stage one	335	75.5
	Stage two	64	14.4
	Stage three	45	10.1

Table 4 Logistic Regression Analysis of Factors Associated with PCCL in a Selected Hospital, Southwest Ethiopia, 2018

Variables		PCCL		COR (95% CI)	AOR (95% CI)	p-value
		No n(%)	Yes n(%)
Age	20–29	97(87.4)	14(12.6)	0.079(0.016,0.15)	0.185(0.036,0.939)*	0.04
	30–39	241(87.6)	33(12.4)	0.074(0.015,0.084)	0.019(0.005,0.081)*	0.01
	>40	21(35.5)	38(64.5)	1	1
Age at first sexual intercourse	<15	165(68.9)	69(31.1)	0.896(0.023,1.545)	1.348(0.222,8.204)	0.17
	15–17	179(95.5)	9(4.5)	0.107(0.002,0.65)	0.123(0.015,1.029)
	>18	15(40)	7(60)	1	1
Life time number of sexual partners	One	131(92.2)	11(7.8)	0.258(0.141,0.542)	0.133(0.024,0.726)*	0.04
	Two or more	228(75.5)	74(24.5)	1	1
Current use of HAART	Yes	235(83.9)	45(16.1)	1	1	0.026
	No	124(75.6)	40(24.4)	1.684(1.120,2.956)	2.31(1.23–4.39) *
Ever history of STI	Yes	56(41.8)	78(58.2)	1	1	0.001
	No	303(97.7)	7(2.3)	0.016(0.005,0.028)	0.026(0.006,0.116) *
Ever had history of genital wart	Yes	50(55.5)	40(44.5)	1	1	0.001
	No	309(87.2)	45(12.8)	0.182(0.071,0.217)	0.261(0.073,0.934)*

Note: *Statistically significant at P < 0.05.